The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies

Article de revue scientifique

Avec comité de lecture

Clifton O. Bingham, David Walker, Peter Nash, Susan J. Lee, Lei Ye, Hao Hu, Javaria Mona Khalid et Bernard Combe

Arthritis research & therapy, Vol.24(1), p.11-14

03/01/2022

PMID: 34980223

Indicateurs

1 Consultations de la notice

Titre: The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies
Créateurs - sans rôle: Clifton O. Bingham - 5200 Eastern Avenue, Mason F. Lord Bldg, Center Tower, Room 434A, Baltimore, MD 21224 USA
David Walker - Northumbria Healthcare Trust, North Shields, UK
Peter Nash - Brisbane, QLD Australia
Susan J. Lee - Foster City, CA USA
Lei Ye - Foster City, CA USA
Hao Hu - Foster City, CA USA
Javaria Mona Khalid - Leiden, Netherlands
Bernard Combe - Montpellier, France
Détails de publication: Arthritis research & therapy, Vol.24(1), p.11-14
Éditeur: BioMed Central
Note de subvention: ;
Identifiants: 99234107809311
Unité académique: IGMM - Institut de Génétique Moléculaire de Montpellier
Langue: Anglais
Type de ressource: Article de revue scientifique